About Spravato

Spravato® (esketamine) is an innovative FDA-approved treatment designed for adults living with treatment-resistant depression. For individuals who have struggled to find relief with traditional antidepressant medications, Spravato offers a new approach that may help improve symptoms more rapidly than conventional treatments alone.

Administered as a nasal spray in a safe and supervised clinical setting, Spravato works differently from standard antidepressants by targeting glutamate pathways in the brain, helping to restore healthy neural connections associated with mood and emotional well-being. Each treatment is carefully monitored by our experienced medical team to ensure patient safety, comfort, and support throughout the process.

At our clinic, we understand how exhausting and discouraging ongoing depression can feel. Our goal is to provide compassionate, personalized care while helping patients explore advanced treatment options that may lead to meaningful improvement and a better quality of life.

Candidates for Spravato treatment typically include adults diagnosed with treatment-resistant depression or major depressive disorder with suicidal thoughts or actions. A comprehensive psychiatric evaluation is completed to determine whether Spravato is an appropriate option for each individual.

If you are interested in learning more about Spravato or would like to schedule a consultation, our team is here to help guide you through every step of the process.